Industry Background:
Medical Intravascular catheters are essential to the practice of modern medicine. Although technological advances have improved the safety of these devices, catheter-related infections remain a major problem such as catheter-related bloodstream infections (CRBSI), local site infections, endocarditis, septic thrombophlebitis, and other metastatic infection. However, technological advancements are anticipated to eliminate associated infections, thereby increasing demand for the same over the forecast period.
According to AMA Research, the market for Medical Intravascular Catheters is expected to register a CAGR of 9.4% during the forecast period to 2030. This growth is primarily driven by Increasing Incidence of Cardiovascular Disorders, Neurological Disorders, among Others
.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Volume Unit | K Unit |
Value Unit | USD (Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Medical Devices sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Abbott Laboratories (United States), Boston Scientific Corporation (United States), Cook Medical (United States), Cordis Corporation (United States), Medtronic plc (Ireland), Smiths Medical (United States), St. Jude Medical (United States), Edwards Life Sciences Corporation (United States), Johnson & Johnson (United States), McKesson Medical Surgical Inc (United States) and Terumo Corporation (Japan), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
In Nov 2019, Shockwave Medical, Inc. announced commercial availability of the Shockwave S4 Peripheral IVL Catheter in select approved geographies. Shockwave S4 is a low-profile catheter specifically designed to access and treat challenging calcified lesions in below-the-knee (BTK) arteries that are frequently associated with critical limb ischemia (CLI), a serious condition associated with significant morbidity and mortality.
In Jan 2021, Avinger, Inc. announced the full commercial launch of its Tigereye™ image-guided chronic total occlusion (CTO) crossing system. With the initiation of a full commercial launch, current and prospective accounts throughout the US and Germany are now able to order the Tigereye device.The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Influencing Trend:
Rapid Improvement in Intravascular Catheter Technology
Market Growth Drivers:
Increasing Incidence of Cardiovascular Disorders, Neurological Disorders, among Others and Rising Inpatient and Emergency Room Procedures
Challenges:
Stringent Government Rules and Regulations
Restraints:
Side-effects associated with the Catheters
Opportunities:
Constantly Improving Healthcare Infrastructure, Increasing Healthcare Expenditure Levels and Increased Research and Development Activities
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Medical Intravascular Catheters Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Medical Intravascular Catheters Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.
The primary interviews and data collected as per the below protocols: By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Medical Intravascular Catheters players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Medical Intravascular Catheters Study Sheds Light on
The Medical Intravascular Catheters Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Medical Intravascular Catheters industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Medical Intravascular Catheters industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.